Late results of catheter-directed recombinant tissue plasminogen activator fibrinolytic therapy of iliofemoral deep venous thrombosis

Casella, Ivan Benaduce; Presti, Calógero; Aun, Ricardo; Benabou, Joseph Elias; Puech-Leão, Pedro.
Clinics ; 62(1): 31-40, Feb. 2007. tab
Artículo en Inglés | LILACS | ID: lil-441823

Documentos relacionados

  1. Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.
  2. Does the administration of sonothrombolysis along with tissue plasminogen activator improve outcomes in acute ischemic stroke? A systematic review and meta-analysis.
  3. Basic data related to thrombolytic therapy for acute venous thrombosis.
  4. Redistribution of TPA Fluxes in the Presence of PAI-1 Regulates Spatial Thrombolysis.
  5. An intelligent DNA nanodevice for precision thrombolysis.
  6. Utilization and outcomes with low dose tissue plasminogen activator as intravenous thrombolytic therapy for ischaemic stroke at Aga Khan University Hospital, Karachi: a retrospective analysis.
  7. The perplexity of catheter-directed thrombolysis for deep venous thrombosis: the approaches play an important role.
  8. Effect of microbubbles on transcranial doppler ultrasound-assisted intracranial recombinant tissue-type plasminogen activator thrombolysis.
  9. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute pulmonary embolism: A multicenter comparison of patient-centered outcomes.
  10. Neonatal renal vein thrombosis: role of anticoagulation and thrombolysis--an institutional review.